Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease

Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease

(2017) Andrew B. West   EXPERIMENTAL NEUROLOGY

MDS clinical diagnostic criteria for Parkinson's disease

(2015) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease

(2012) Ekaterina Yonova-Doing et al.   PARKINSONISM & RELATED DISORDERS

Screening LRRK2 gene mutations in patients with Parkinson’s disease in Ghana

(2011) Roberto Cilia et al.   JOURNAL OF NEUROLOGY

LRRK2 G2019S in the North African Population: A Review

(2010) Hani T.S. Benamer et al.   EUROPEAN NEUROLOGY

Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans

(2010) Suzanne Lesage et al.   HUMAN MOLECULAR GENETICS

LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson’s disease patients

(2010) Soraya Bardien et al.   JOURNAL OF NEURAL TRANSMISSION

LRRK2gene variation and its contribution to Parkinson disease

(2009) Coro Paisán-Ruiz   HUMAN MUTATION

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review

(2009) L. Correia Guedes et al.   PARKINSONISM & RELATED DISORDERS

Is the G2019S LRRK2 mutation common in all southern European populations?

(2008) Spiridon Papapetropoulos et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

(2008) Daniel G Healy et al.   LANCET NEUROLOGY

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Analysis of Nigerians with Apparently Sporadic Parkinson Disease for Mutations in LRRK2, PRKN and ATXN3

(2008) Njideka Okubadejo et al.   PLoS One